Oct 24 |
How CIOs gain employee buy-in on generative AI
|
Oct 24 |
Monopar stock climbs as it takes over Wilson disease drug candidate
|
Oct 23 |
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
|
Oct 23 |
How The Oncology Sector Is Set To Fuel AstraZeneca’s (AZN) Growth
|
Oct 22 |
AstraZeneca Receives CHMP's Approval for Wainzua in Europe
|
Oct 22 |
EU CHMP recommends AstraZeneca and Ionis’ Wainzua for ATTRv-PN
|
Oct 21 |
UK Stocks That May Be Trading Below Estimated Value
|
Oct 20 |
With 72% ownership, AstraZeneca PLC (LON:AZN) boasts of strong institutional backing
|
Oct 17 |
AstraZeneca (AZN): High-Growth UK Stock with Strong Pipeline
|
Oct 17 |
The Zacks Analyst Blog Highlights AstraZeneca, Accenture, AT&T and National Presto Industries
|